Promoter methylation of serotonin transporter gene is associated with obesity measures: A monozygotic twin study

International Journal of Obesity

Volumn 37, Issue 1, 2013, Pages 140-145

  Zhao, J ^a   Goldberg, J ^b,c   Vaccarino, V ^d  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b Veterans Affairs Office of Research and Development   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

DNA methylation; monozygotic twins; serotonin transporter gene; SLC6A4

Indexed keywords

ALCOHOL; BISULFITE; SEROTONIN TRANSPORTER;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; FEMALE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MONOZYGOTIC TWINS; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; SMOKING; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; DNA METHYLATION; HUMANS; MALE; MIDDLE AGED; OBESITY; PROMOTER REGIONS, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TWINS, MONOZYGOTIC; VETERANS;

EID: 84872113159     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2012.8     Document Type: Article

References (45)

1. WHO (ed.). Global health risks: mortality and burden of disease attributable to selected major risks. WHO: Geneva, 2009.
2. Franks PW, Ling C. Epigenetics and obesity: the devil is in the details. BMC Med 2010; 8: 88.
3. King PJ. The hypothalamus and obesity. Curr Drug Targets 2005; 6: 225-240.
4. Saller CF, Stricker EM. Hyperphagia and increased growth in rats after intraventricular injection of 5,7-dihydroxytryptamine. Science 1976; 192: 385-387.
5. Breisch ST, Zemlan FP, Hoebel BG. Hyperphagia and obesity following serotonin depletion by intraventricular p-chlorophenylalanine.Science 1976; 192: 382-385.
6. Simansky KJ. Serotonergic control of the organization of feeding and satiety. Behav Brain Res 1996; 73: 37-42.
7. Heisler LK, Chu HM, Tecott LH. Epilepsy and obesity in serotonin 5-HT2C receptor mutant mice. Ann NY Acad Sci 1998; 861: 74-78.
8. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-1531.
9. Calati R, De Ronchi D, Bellini M, Serretti A. The 5-HTTLPR polymorphism and eating disorders: a meta-analysis. Int J Eat Disord 2011; 44: 191 -199.
10. Lan MY, Chang YY, Chen WH, Kao YF, Lin HS, Liu JS. Serotonin transporter gene promoter polymorphism is associated with body mass index and obesity in non-elderly stroke patients. J Endocrinol Invest 2009; 32: 119-122.
11. Sookoian S, Gianotti TF, Gemma C, Burgueno A, Pirola CJ. Contribution of the functional 5-HTTLPR variant of the SLC6A4 gene to obesity risk in male adults. Obesity (Silver Spring) 2008; 16: 488-491.
12. Iordanidou M, Tavridou A, Petridis I, Arvanitidis KI, Christakidis D, Vargemezis V etal. The serotonin transporter promoter polymorphism (5-HTTLPR) is associated with type 2 diabetes. Clin Chim Acta 2010; 411: 167-171.
13. Toperoff G, Aran D, Kark JD, Rosenberg M, Dubnikov T, Nissan B et al. Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum Mol Genet 2011; 21: 371 -383.
14. Mergen H, Karaaslan C, Mergen M, Deniz Ozsoy E, Ozata M. LEPR, ADBR3, IRS-1 and 5-HTT genes polymorphisms do not associate with obesity. Endocr J 2007; 54: 89-94.
15. Hinney A, Barth N, Ziegler A, von Prittwitz S, Hamann A, Hennighausen K et al. Serotonin transporter gene-linked polymorphic region: allele distributions in relationship to bodyweightand in anorexia nervosa. Life Sci 1997;61: PL295-PL303.
16. Chong S, Whitelaw E. Epigenetic germline inheritance. Curr Opin Genet Dev 2004; 14: 692-696.
17. Goldberg J, Curran B, Vitek ME, Henderson WG, Boyko EJ. The Vietnam Era Twin Registry. Twin Res 2002; 5: 476-481.
18. Shah AJ, Su S, Veledar E, Bremner JD, Goldstein FC, Lampert R et al. Is heart rate variability related to memory performance in middle-aged men? Psychosom Med 2011; 73: 475-482.
19. Richardson MT, Ainsworth BE, Wu HC, Jacobs Jr DR, Leon AS. Ability of the Atherosclerosis Risk in Communities (ARIC)/Baecke Questionnaire to assess leisure-time physical activity. Int J Epidemiol 1995; 24: 685-693.
20. Willett W. Food Frequency Methods, in Nutritional Epidemiology. Oxford University Press: New York, NY, 1998, pp 74-91.
21. Benjamin Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. Ser B (Methodol) 1995; 57: 289-300.
22. Nieuwenhuizen AG, Rutters F. The hypothalamic-pituitary-adrenal-axis in the regulation of energy balance. Physiol Behav 2008; 94: 169-177.
23. Rutters F, Nieuwenhuizen AG, Lemmens SG, Born JM, Westerterp-Plantenga MS. Hypothalamic-pituitary-adrenal (HPA) axis functioning in relation to body fat distribution. Clin Endocrinol (Oxf) 2010; 72: 738-743.
24. Homberg JR, la Fleur SE, Cuppen E. Serotonin transporter deficiency increases abdominal fat in female, but not male rats. Obesity (Silver Spring) 2010; 18: 137-145.
25. Tallett AJ, Blundell JE, Rodgers RJ. Sibutramine-induced anorexia: potent, dose-dependent and behaviourally-selective profile in male rats. Behav Brain Res 2009; 198: 359-365.
26. Meguid MM, Fetissov SO, Varma M, Sato T, Zhang L, Laviano A et al. Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition 2000; 16: 843-857.
27. Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev 2005; 15: 490-495.
28. Breum L, Rasmussen MH, Hilsted J, Fernstrom JD. Twenty-four-hour plasma tryptophan concentrations and ratios are below normal in obese subjects and are not normalized by substantial weight reduction. Am J Clin Nutr 2003; 77: 1112-1118.
29. Torres SJ, Nowson CA. Relationship between stress, eating behavior, and obesity. Nutrition 2007; 23: 887-894.
30. Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, Mc Donald OG et al. Increased methylation variation in epigenetic domains across cancer types. Nat Genet 2011; 43: 768-775.
31. Aronne LJ. Classification of obesity and assessment of obesity-related health risks. Obes Res 2002; 10 (Suppl 2): 105S-115S.
32. Goran MI, Gower BA, Treuth M, Nagy TR. Prediction of intra-abdominal and subcutaneous abdominal adipose tissue in healthy pre-pubertal children. Int J Obes Relat Metab Disord 1998; 22: 549-558.
33. Taylor RW, Keil D, Gold EJ, Williams SM, Goulding A. Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves. Am J Clin Nutr 1998; 67: 44-49.
34. Taylor RW, Jones IE, Williams SM, Goulding A. Evaluation of waist circumference, waist-to-hip ratio, and the conicity index as screening tools for high trunk fat mass, as measured by dual-energy X-ray absorptiometry, in children aged 3-19 y. Am J Clin Nutr 2000; 72: 490-495.
35. Neovius M, Linne Y, Rossner S. BMI, waist-circumference and waist-hip-ratio as diagnostic tests for fatness in adolescents. Int J Obes (Lond) 2005; 29: 163-169.
36. Aronne LJ, Segal KR. Adiposity and fat distribution outcome measures: assessment and clinical implications. Obes Res 2002; 10 (Suppl 1): 14S-21S.
37. Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 2010; 11: 11-18.
38. Clasey JL, Kanaley JA, Wideman L, Heymsfield SB, Teates CD, Gutgesell ME et al. Validity of methods of body composition assessment in young and older men and women. J Appl Physiol 1999; 86: 1728-1738.
39. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006; 355: 763-778.
40. Balkau B, Deanfield JE, Despres JP, Bassand JP, Fox KA, Smith Jr SC et al. International Dayfor the Evaluation of Abdominal Obesity (IDEA): a study ofwaist circumference, cardiovascular disease, and diabetes mellitus in 168 000 primary care patients in 63 countries. Circulation 2007; 116: 1942-1951.
41. Probst AV, Dunleavy E, Almouzni G. Epigenetic inheritance during the cell cycle. Nat Rev Mol Cell Biol 2009; 10: 192 - 206.
42. Morgan DK, Whitelaw E. The case for transgenerational epigenetic inheritance in humans. Mamm Genome 2008; 19: 394-397.
43. Relton CL, Davey Smith G. Epigenetic epidemiology of common complex disease: prospects for prediction, prevention, and treatment. PLo SMed 2010; 7: e1000356.
44. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 2005; 102: 10604-10609.
45. Rutten BP, Mill J. Epigenetic mediation of environmental influences in major psychotic disorders. Schizophr Bull 2009; 35: 1045-1056.